Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Comment by MrVerbatim9800on Dec 22, 2020 9:33pm
441 Views
Post# 32166804

RE:Green day tomorrow???

RE:Green day tomorrow???Currently consolidated lots and medium sized bids about 30 levels deep. On the other side are 98% single lots with low/weak asks up to a little speed bump at $4.20 then another bump at $4.50 and $4.75 . There are asks all the way up to $200.00/share (at about 200 levels deep 2 lots 7000 shares) and everything in between. Brokers are supposed to be responsible enough to disallow extremely far reaching bids or asks because it can seriously skew selling VS buying pressure. Basically, at the moment, all signs point to UP right out of the gate, but judging the direction of a stock based on market data (albeit 24hr streaming data) 12 hrs before the market opens isn't the best practice lol
Anyway, at about 10 PM EST the MMED depth data will be upside down and backwards as it has been every day, then 15 minutes before opening it will flip back and the show will begin. What's my point you ask? Well, I don't really have one, but this thing should soon begin to float between $4.00-$5.00 (ish) for a while while we consolidate and settle some of the new financial structure. Even if she dips down a bit and runs over some rolling hills along the way, MMED is heading in the right direction. Anything available to purchase below $3.75 should be condidered a gift...

I'm definitely not an expert and, I am most definitely a novice...... So don't listen to me...... ;)

V


Buddy1959 wrote: Three days of heavy selling we need a green day!!!
Any thoughts on tomorrow??


<< Previous
Bullboard Posts
Next >>